Joe Neel
Joe Neel is NPR's deputy senior supervising editor and a correspondent on the Science Desk.
As a leader of NPR's award-winning health and science team, Neel directs coverage of breaking news in health and science, ranging from disease outbreaks and advances in medical research to debates over health reform and public health.
Joe also plays a key role in overseeing the Science Desk's award-winning enterprise reporting. Among his current projects and responsibilities, Neel supervises the Monday "Your Health" segment on Morning Edition. He also directs several ongoing editorial partnerships. One, a partnership with Kaiser Health News and public radio member stations, focuses on health care in the United States. Another is a polling project on health issues with the Harvard T. H. Chan School of Public Health and the Robert Wood Johnson Foundation.
Neel has played a key role in expanding the network's coverage of global health and development issues. He is currently focused on domestic health issues, including cutting-edge biomedical research and developments in the health industry, such as the Affordable Care Act.
In 2008, he launched NPR's "Your Health" podcast and helped launch and grow "Shots," NPR's health blog, in 2010.
In addition to his responsibilities at NPR's Science Desk, Neel also regularly serves as newsroom manager, overseeing the network's overall news coverage.
During his tenure as editor, NPR's health reporters and correspondents have won numerous awards, including the George Foster Peabody Award, the National Academy of Sciences Communication Award, the Sigma Delta Chi Award from the Society for Professional Journalists, the Everett McKinley Dirksen Award for Distinguished Reporting on Congress, the American Association for the Advancement of Science's Journalism Prize, and the Association of Health Care Journalism award. Neel was awarded the prestigious Kaiser Family Foundation Media Fellowship in 2007.
Neel started filing stories about medicine and health as a freelancer for NPR in 1994 and joined the staff two years later.
He earned bachelor degrees from Washington University in St. Louis in both biology and German literature and language. He also studied biology at the Universitaet Tuebingen in Germany.
-
In advance of a COVID-19 vaccine being available, a group of independent medical advisers to the Centers for Disease Control and Prevention weighed Friday who should get the vaccine first and how. -
In the largest U.S. cities, at least half of all households have seen a serious financial loss such as lost job, wages or savings. Many problems are concentrated in Black and Latino households.
-
Emily Miller was central in defending the FDA commissioner, Dr. Stephen Hahn, after he falsely said that blood plasma could lower the death rate from COVID-19 by more than a third. -
The agency said Friday that using hydroxychloroquine and a related compound, chloroquine, for COVID-19 may cause life-threatening side effects. That warning contradicts the president's own enthusiasm. -
In a study of the early coronavirus epidemic in the U.S., a third of people who were hospitalized were African American. Top risk factors were high blood pressure and obesity.
-
The CDC says it is probing 450 reported cases of illness in people who vaped nicotine or cannabis products. Health officials say it's too soon to pinpoint a single product or substance as the cause. -
"Hail more than a meter high, and then we wonder if climate change exists," said Enrique Alfaro Ramírez, the governor of Jalisco state. The Mexican army is helping to dig out the city. -
A new poll from NPR, Harvard and the Robert Wood Johnson Foundation gives a glimpse into rural life in America today, finding that many people living in rural communities live on the edge financially.
-
What's on people's minds in rural America? A new poll shows that the addiction crisis and economic issues have people worried. But many retain an upbeat outlook about the future of their communities.
-
James P. Allison and Tasuku Honjo were cited for their work in harnessing the immune system to arrest the development of cancer.
